Global Stem Cells Group announces that it will represent CELLINK Bioprinting Technology in Latin America. CELLINK is the world’s first company to market bioinks for 3D bioprinting of human organs and tissue.
MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
GSCG will also market CELLINK’S newest product, BIO X printer for researchers, life science companies, and innovators who work with bioprinting on its subsidiary Adimarket.net website.
3D bioprinting of human tissues and organs is a revolutionary technology in the field of tissue engineering. One of the major challenges in stem cell research and tissue engineering is mimicking the micro and macro environment of human tissues. A favorable functional outcome is extremely dependent on the level to which tissue scientist and engineers are able to control the inner micro- and macro-scale features of engineered-tissue. In response to this challenge, advances in additive manufacturing inspired scientists to develop and adapt 3D bioprinting technology for human tissues and organs.
“Our objective is to bring this cutting-edge 3D bioprinting technology to scientists and regenerative medicine researcher throughout Lain America,” says Global Stem Cells Group founder and CEO Benito Novas. “CELLINK has revolutionized tissue engineering with its range of bioprinters, and we’re excited to make this process available to scientists and regenerative medicine researchers in Mexico, Central America, and South America.
“This opportunity is ideally suited to Global Stem Cells’ commitment to advancing the benefits of stem cell medicine in Latin America and worldwide, Novas says.”
To learn more about Global Stem Cells Group, visit the GSCG website, email firstname.lastname@example.org, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
CELLLINK 3D bioprinting technology